Progyny Inc. (PGNY)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook
Progyny NASDAQ: PGNY CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client commitments have increased management's confidence in its outlook for the remainder of the year.
Progyny Q2 Earnings Call Highlights
Progyny NASDAQ: PGNY reported record quarterly revenue, gross profit and adjusted EBITDA for the second quarter of 2026, while management said early sales commitments and client-retention activity have positioned the company favorably for the 2027 selling season.
Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript
Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
Progyny (PGNY) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.48 per share a year ago.
Progyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Progyny (PGNY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Progyny (PGNY) Might be Well Poised for a Surge
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Are You Looking for a Top Momentum Pick? Why Progyny (PGNY) is a Great Choice
Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.
What Makes Progyny (PGNY) a New Strong Buy Stock
Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript
Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript
Bull of the Day: Progyny (PGNY)
For growth investors seeking exposure to a differentiated healthcare disruptor with strong secular tailwinds, Progyny (PGNY) stock deserves a close look.
